SCHEMBL24577305

SCHEMBL24577305

CC1NC=C(NC(=O)OC(C)(C)C)C=C1NC(=O)c1cnn2cc(Br)sc12

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 1/20 0.31
▸ IRAK4 Q9NWZ3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24577436 0.84 GLS (0.36) IRAK4
SCHEMBL24577343 0.81 HDAC6 (0.33) IRAK4
SCHEMBL24577955 0.81 NPC1 (0.30) —
SCHEMBL24577488 0.80 — —
SCHEMBL24579060 0.79 KDM1A (0.31) —
SCHEMBL24578956 0.79 — —
SCHEMBL24579106 0.79 RAB9A (0.34) —
SCHEMBL24577394 0.79 POLB (0.33) —
SCHEMBL24578957 0.79 RAB9A (0.34) —
SCHEMBL24579051 0.78 IRAK4 (0.31) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback